Work

Real‐World Effectiveness and Safety of Lebrikizumab in Moderate‐to‐Severe Atopic Dermatitis: A Multicenter Study From Spain

Year: 2025

Type: article

Abstract: The authors declare no conflicts of interest. The data that support the findings of this study are available from the corresponding author upon reasonable request.

Source: International Journal of Dermatology

DOI: 10.1111/ijd.70185

Authors: Jose Carlos Armario‐Hita, Manuel Galán‐Gutierrez, Jose Juan Pereyra‐Rodríguez, Jorge Suarez‐Pérez, Mercedes Rodríguez‐Serna, Javier Ortiz de Frutos, Jose Manuel Carrascosa, Esther Serra‐Baldrich, Ignasi Figueras‐Nar, Violeta Zaragoza‐Ninet, Ricardo Ruiz‐Villaverde

Institutions: Universidad de Cádiz, Hospital Universitario Puerto Real, Hospital Universitario Reina Sofía, Hospital Universitario Virgen del Rocío, Universidad de Sevilla, Hospital Clínico Universitario Virgen de la Victoria, Hospital Universitari i Politècnic La Fe, Hospital Universitario 12 De Octubre, Hospital Universitari Germans Trias i Pujol, Hospital de Sant Pau, Bellvitge University Hospital, Hospital General Universitario De Valencia

Language: English

Topic: Dermatology and Skin Diseases

Subfield: Dermatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4416773269

FWCI: 1.606

Cites: 3

Cited by: 2

Related to: